Chemomab Therapeutics Ltd.(CMMB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CMMB Chemomab Therapeutics Ltd.

交易中 03-25 11:10:59 EDT

1.65

+0.08

+5.10%

最高1.72	最低1.58	成交量4.03万
今开1.68	昨收1.57	日振幅9.20%
总市值1,188万	流通市值1,051万	总股本720.04万
成交额6.65万	换手率0.63%	流通股本637.22万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CMMB","market":"US","secType":"STK","nameCN":"Chemomab Therapeutics Ltd.","latestPrice":1.65,"timestamp":1774451181321,"preClose":1.57,"halted":0,"volume":40293,"delay":0,"changeRate":0.05095541401273875,"floatShares":6372200,"shares":7200400,"eps":-1.41035,"marketStatus":"交易中","change":0.08,"latestTime":"03-25 11:10:59 EDT","open":1.68,"high":1.7244,"low":1.58,"amount":66521.1118671,"amplitude":0.091975,"askPrice":1.66,"askSize":139,"bidPrice":1.56,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.41035,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1774468800000},"marketStatusCode":2,"adr":0,"adrRate":80,"listingDate":1549947600000,"exchange":"NASDAQ","adjPreClose":1.57,"preHourTrading":{"tag":"盘前","latestPrice":1.65,"preClose":1.57,"latestTime":"08:23 EDT","volume":477,"amount":793.157985,"timestamp":1774441408742,"change":0.08,"changeRate":0.050955,"amplitude":0.119236},"postHourTrading":{"tag":"盘后","latestPrice":1.63,"preClose":1.57,"latestTime":"19:55 EDT","volume":321,"amount":513.165,"timestamp":1774396510171,"change":0.06,"changeRate":0.038217,"amplitude":0.044586},"volumeRatio":2.879243},"requestUrl":"/m/hq/s/CMMB","defaultTab":"news","newsList":[{"id":"1117558182","title":"Chemomab Therapeutics：评估Nebokitug产生强劲临床前疗效信号的更多适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=1117558182","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117558182?lang=zh_cn&edition=full","pubTime":"2026-03-19 20:10","pubTimestamp":1773922204,"startTime":"0","endTime":"0","summary":"Chemomab Therapeutics Ltd. 正在积极探索其核心候选药物Nebokitug的更多潜在治疗领域。目前，公司已基于该药物在临床前研究中展现出的强劲疗效信号，着手评估其应用于其他疾病适应症的可能性。这一举措旨在充分挖掘Nebokitug的治疗潜力，为未来拓展其临床应用范围奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMMB","BK4139"],"gpt_icon":0},{"id":"1162316031","title":"Chemomab Therapeutics发布主要硬化性胆管炎Nebokitug二期春季试验结果，发表在《美国胃肠病学杂志》上","url":"https://stock-news.laohu8.com/highlight/detail?id=1162316031","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162316031?lang=zh_cn&edition=full","pubTime":"2025-12-02 21:01","pubTimestamp":1764680508,"startTime":"0","endTime":"0","summary":"Chemomab Therapeutics发布主要硬化性胆管炎Nebokitug二期春季试验结果，发表在《美国胃肠病学杂志》上。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CMMB"],"gpt_icon":0},{"id":"2583951358","title":"Chemomab Therapeutics Ltd盘中异动 早盘快速跳水5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583951358","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583951358?lang=zh_cn&edition=full","pubTime":"2025-11-14 00:25","pubTimestamp":1763051113,"startTime":"0","endTime":"0","summary":"北京时间2025年11月14日00时25分，Chemomab Therapeutics Ltd股票出现波动，股价急速下挫5.60%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体涨幅为0.63%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111400251397677f5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111400251397677f5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4539","CMMB","LENZ","BK4139"],"gpt_icon":0},{"id":"1197157247","title":"Chemomab在2025年AASLD肝脏会议上公布Nebokitug II期临床试验的多项研究数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1197157247","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197157247?lang=zh_cn&edition=full","pubTime":"2025-11-06 21:02","pubTimestamp":1762434126,"startTime":"0","endTime":"0","summary":"Chemomab在2025年AASLD肝脏会议上公布了基于Nebokitug II期临床试验的多项研究数据，研究集中在原发性硬化性胆管炎领域。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMMB","BK4139"],"gpt_icon":0},{"id":"2518205270","title":"Chemomab Therapeutics Ltd盘中异动 股价大涨5.60%报1.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518205270","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518205270?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:34","pubTimestamp":1741628065,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日01时34分，Chemomab Therapeutics Ltd股票出现异动，股价快速上涨5.60%。截至发稿，该股报1.32美元/股，成交量4.027万股，换手率0.21%，振幅7.20%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体涨幅为0.84%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311013426abf35526&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311013426abf35526&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CMMB","LENZ"],"gpt_icon":0},{"id":"2518428095","title":"Chemomab Therapeutics Ltd2024财年实现净利润-14.01百万美元，同比增加42.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518428095","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518428095?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:01","pubTimestamp":1741449676,"startTime":"0","endTime":"0","summary":"3月9日，Chemomab Therapeutics Ltd公布财报，公告显示公司2024财年净利润为-14.01百万美元，同比增加42.01%；其中营业收入为0.00美元，每股基本收益为-0.86美元。从资产负债表来看，Chemomab Therapeutics Ltd总负债3.43百万美元，其中短期债务114999.97美元，资产负债比为4.95，流动比率为4.99。机构评级：截至2025年3月9日，当前有3家机构对Chemomab Therapeutics Ltd目标价做出预测，其中目标均价为9.00美元，其中最低目标价为7.00美元，最高目标价为11.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000247abef9898&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000247abef9898&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CMMB","LENZ"],"gpt_icon":0},{"id":"2517623381","title":"Chemomab Therapeutics Ltd盘中异动 早盘股价大涨6.43%报1.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517623381","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517623381?lang=zh_cn&edition=full","pubTime":"2025-03-06 23:57","pubTimestamp":1741276670,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日23时57分，Chemomab Therapeutics Ltd股票出现波动，股价急速上涨6.43%。截至发稿，该股报1.49美元/股，成交量1.4753万股，换手率0.08%，振幅4.29%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体跌幅为0.58%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306235750989ec4fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306235750989ec4fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CMMB"],"gpt_icon":0},{"id":"2517910044","title":"Chemomab Therapeutics Ltd盘中异动 早盘股价大涨9.47%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517910044","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517910044?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:32","pubTimestamp":1741185125,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时32分，Chemomab Therapeutics Ltd股票出现异动，股价快速上涨9.47%。截至发稿，该股报1.42美元/股，成交量1202股，换手率0.01%，振幅4.23%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体涨幅为0.20%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223205a260c786&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223205a260c786&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CMMB"],"gpt_icon":0},{"id":"2516166819","title":"Chemomab Therapeutics Ltd盘中异动 急速下挫5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516166819","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516166819?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:16","pubTimestamp":1741032963,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时16分，Chemomab Therapeutics Ltd股票出现波动，股价快速跳水5.35%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体涨幅为0.01%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304041603989a5c4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304041603989a5c4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CMMB","BK4139","LENZ"],"gpt_icon":0},{"id":"1188217444","title":"Chemomab Therapeutics第四季度每股收益$(0.008)与去年同期$(0.013)对比","url":"https://stock-news.laohu8.com/highlight/detail?id=1188217444","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188217444?lang=zh_cn&edition=full","pubTime":"2025-03-03 21:12","pubTimestamp":1741007561,"startTime":"0","endTime":"0","summary":"Chemomab Therapeutics(LENZ)第四季度每股收益$(0.008)与去年同期$(0.013)对比。以上内容来自Benzinga Earnings专栏，原文如下：Chemomab $Therapeutics(LENZ)$ Q4 EPS $(0.008) vs $(0.013) YoY","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMMB","LENZ"],"gpt_icon":0},{"id":"2516301312","title":"Chemomab Therapeutics Ltd盘中异动 急速上涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516301312","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516301312?lang=zh_cn&edition=full","pubTime":"2025-03-01 04:58","pubTimestamp":1740776337,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日04时58分，Chemomab Therapeutics Ltd股票出现波动，股价急速上涨5.56%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体涨幅为0.69%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301045858a25856de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301045858a25856de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CMMB","LENZ"],"gpt_icon":0},{"id":"2514096013","title":"Chemomab Therapeutics Ltd盘中异动 大幅下跌5.95%报1.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514096013","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514096013?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:20","pubTimestamp":1740496823,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时20分，Chemomab Therapeutics Ltd股票出现波动，股价大幅下跌5.95%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体涨幅为0.83%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。CM-101已经显示出有潜力治疗多种严重和危及生命的纤维化和炎症性疾病。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225232023989257c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225232023989257c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CMMB","BK4139"],"gpt_icon":0},{"id":"2513296346","title":"Chemomab Therapeutics Ltd盘中异动 早盘股价大跌5.65%报1.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513296346","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513296346?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:31","pubTimestamp":1740148304,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时31分，Chemomab Therapeutics Ltd股票出现异动，股价快速跳水5.65%。截至发稿，该股报1.67美元/股，成交量2.9292万股，换手率0.16%，振幅2.26%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体涨幅为0.33%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223145988dde1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223145988dde1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CMMB","BK4139","LENZ"],"gpt_icon":0},{"id":"2512488052","title":"Chemomab Therapeutics Ltd盘中异动 早盘快速下挫5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512488052","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512488052?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:32","pubTimestamp":1739975570,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时32分，Chemomab Therapeutics Ltd股票出现异动，股价大幅跳水5.02%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Osr Holdings Inc C/Wts 02/09/2028 、Aditxt, Inc.、Citius Pharmaceuticals, Inc.涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Chemomab Therapeutics Ltd较为活跃，换手率分别为216.00%、203.69%、66.10%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Aditxt, Inc.，振幅分别为207.68%、11.48%、11.45%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223250a24bf9d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223250a24bf9d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CMMB"],"gpt_icon":0},{"id":"2510863479","title":"Chemomab Therapeutics Ltd盘中异动 急速上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510863479","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510863479?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:32","pubTimestamp":1739197950,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时32分，Chemomab Therapeutics Ltd股票出现异动，股价快速拉升5.05%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体涨幅为0.33%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223230961e0018&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223230961e0018&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CMMB","LENZ"],"gpt_icon":0},{"id":"2509720403","title":"Chemomab Therapeutics Ltd盘中异动 股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509720403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509720403?lang=zh_cn&edition=full","pubTime":"2025-02-08 02:45","pubTimestamp":1738953957,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日02时45分，Chemomab Therapeutics Ltd股票出现异动，股价大幅下跌5.26%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体跌幅为0.70%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208024557abc65fe0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208024557abc65fe0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CMMB","LENZ"],"gpt_icon":0},{"id":"2509287907","title":"Chemomab Therapeutics Ltd盘中异动 大幅拉升5.31%报2.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509287907","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509287907?lang=zh_cn&edition=full","pubTime":"2025-02-05 22:56","pubTimestamp":1738767386,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日22时56分，Chemomab Therapeutics Ltd股票出现波动，股价快速上涨5.31%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体涨幅为1.65%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。CM-101已经显示出有潜力治疗多种严重和危及生命的纤维化和炎症性疾病。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205225626abc382d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205225626abc382d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CMMB","LENZ","BK4139"],"gpt_icon":0},{"id":"2507575616","title":"Chemomab Therapeutics Ltd盘中异动 下午盘大幅下挫5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507575616","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507575616?lang=zh_cn&edition=full","pubTime":"2025-01-30 03:09","pubTimestamp":1738177785,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日03时09分，Chemomab Therapeutics Ltd股票出现异动，股价大幅下挫5.26%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体涨幅为1.10%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130030945abbc8a22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130030945abbc8a22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CMMB","LENZ","BK4139"],"gpt_icon":0},{"id":"2503628461","title":"Chemomab Therapeutics Ltd盘中异动 早盘股价大涨6.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503628461","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503628461?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:55","pubTimestamp":1736952910,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时55分，Chemomab Therapeutics Ltd股票出现异动，股价大幅上涨6.76%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体涨幅为0.82%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。CM-101已经显示出有潜力治疗多种严重和危及生命的纤维化和炎症性疾病。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115225510a223045e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115225510a223045e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CMMB"],"gpt_icon":0},{"id":"2503858999","title":"Chemomab Therapeutics Ltd盘中异动 快速下挫5.19%报2.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503858999","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503858999?lang=zh_cn&edition=full","pubTime":"2025-01-13 23:06","pubTimestamp":1736780804,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日23时06分，Chemomab Therapeutics Ltd股票出现异动，股价快速跳水5.19%。Chemomab Therapeutics Ltd股票所在的生物技术行业中，整体跌幅为1.17%。Chemomab Therapeutics Ltd公司简介：Chemomab Therapeutics Ltd 是一家临床阶段的生物科技公司，专注于发现和开发针对具有迫切需求的纤维化相关疾病的治疗方法。CM-101已经显示出有潜力治疗多种严重和危及生命的纤维化和炎症性疾病。该公司正在同时推进三项针对CM-101用于治疗罕见纤维化病症的二期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113230644a2204804&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113230644a2204804&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CMMB","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chemomab.com","stockEarnings":[{"period":"1week","weight":-0.2379},{"period":"1month","weight":0},{"period":"3month","weight":-0.1649},{"period":"6month","weight":-0.372},{"period":"1year","weight":-0.6835},{"period":"ytd","weight":-0.0485}],"compareEarnings":[{"period":"1week","weight":-0.0263},{"period":"1month","weight":-0.0526},{"period":"3month","weight":-0.0539},{"period":"6month","weight":-0.0074},{"period":"1year","weight":0.1378},{"period":"ytd","weight":-0.0421}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Chemomab Therapeutics Ltd.于2011年9月22日根据以色列公司法在以色列注册成立。Chemomab是一家处于临床阶段的生物技术公司，致力于发现和开发针对高度未满足需求的纤维化相关疾病的创新疗法。 基于可溶性蛋白CCL24在促进纤维化和炎症中的独特和关键作用，Chemomab开发了CM-101，这是一种旨在结合和阻断CCL24活性的单克隆抗体。 CM-101具有治疗多种严重且威胁生命的炎性和纤维化疾病的潜力，目前正针对孤儿疾病，原发性硬化性胆管炎（PSC）和系统性硬化症（SSc）进行临床开发。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.036667},{"month":2,"riseRate":0.428571,"avgChangeRate":0.031068},{"month":3,"riseRate":0.375,"avgChangeRate":-0.127449},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.03511},{"month":5,"riseRate":0.428571,"avgChangeRate":0.032258},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.001917},{"month":7,"riseRate":0.142857,"avgChangeRate":-0.107773},{"month":8,"riseRate":0.428571,"avgChangeRate":0.018331},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.138377},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.036203},{"month":11,"riseRate":0.428571,"avgChangeRate":-0.050555},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.00827}],"exchange":"NASDAQ","name":"Chemomab Therapeutics Ltd.","nameEN":"Chemomab Therapeutics Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Chemomab Therapeutics Ltd.(CMMB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Chemomab Therapeutics Ltd.(CMMB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Chemomab Therapeutics Ltd.,CMMB,Chemomab Therapeutics Ltd.股票,Chemomab Therapeutics Ltd.股票老虎,Chemomab Therapeutics Ltd.股票老虎国际,Chemomab Therapeutics Ltd.行情,Chemomab Therapeutics Ltd.股票行情,Chemomab Therapeutics Ltd.股价,Chemomab Therapeutics Ltd.股市,Chemomab Therapeutics Ltd.股票价格,Chemomab Therapeutics Ltd.股票交易,Chemomab Therapeutics Ltd.股票购买,Chemomab Therapeutics Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Chemomab Therapeutics Ltd.(CMMB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Chemomab Therapeutics Ltd.(CMMB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}